Since we last looked at Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA), there has been a disconcerting and unexpected severe decline in the stock, doubtless for capital markets reasons that has then been followed by an extraordinarily robust recovery over the past week or so, again for capital markets reasons since there has been no significant news out of the company and result is that the stock is back very close to recent highs and so the original premise is looking correct especially as the powerful advance of the past week has major bullish implications.
We can see this unusual down and then up action in the stock over the past two months on the 1-year chart below. The extraordinary strength of the recovery over the past week or so is readily apparent.
This rapid recovery has brought the price back up to resistance at the April highs, where it has paused in recent days, and the key point for us to note here is that the power of this advance means that this resistance is unlikely to stop it for long. This action in this stock, with little news to account for it, is taken to mean that "something is going on," and solely on technical ground, it implies that the stock is probably headed much higher.
We, therefore, stay long, and Treatment AI remains a Buy here, especially on any minor near-term dips, although it may not dip before continuing higher.
Treatment.com AI Inc.'s website.
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) closed at CA$0.74, US$0.523 on June 28, 2024.
Want to be the first to know about interesting Biotechnology / Pharmaceuticals, Life Sciences Tools & Diagnostics and Technology investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter.
Subscribe
